The differences were primarily from organ function (exclusive platelets, ANC, hemoglobin, creatinine, AST or ALT, and bilirubin) and comorbidity (HIV, hepatitis) exclusion criteria that weren’t listed on ClinicalTrials.gov. The gene discussed is GPT; the disease is hepatitis A virus infection.